Literature DB >> 18465335

Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol.

Mogens Blichert-Toft1, Maja Nielsen, Maria Düring, Susanne Møller, Fritz Rank, Marie Overgaard, Henning T Mouridsen.   

Abstract

The main objective of the present study aims at comparing the long-term efficacy of breast conserving surgery (BCS) vs. mastectomy (M) based on a randomized design. The Danish Breast Cancer Cooperative Group (DBCG) conducted the trial (DBCG-82TM) from January 1983 to March 1989 recruiting 1154 patients with invasive breast carcinoma. Follow-up time ended 1(st) May 2006 with a median follow-up time of 19.6 years (time span 17.1-23.3 years). Eligibility criteria included a one-sided, unifocal, primary operable breast carcinoma, patient age below 70 years, probability of satisfactory cosmetic outcome with BCS, and no evidence of disseminated disease. The patients accrued were grouped into three subsets: correctly randomized, suspicion of randomization error, and declining randomization. The main analyses focus on the subgroup of 793 correctly randomized patients representing 70% of the complete series. 10-year recurrence free survival (RFS) and 20-year overall survival (OS) based on intent to treat did not reveal significant differences in outcome between breast conserving surgery vs. mastectomy, p=0.95 and p=0.10, respectively. Including the complete series comprising 1133 eligible patients based on treatment in fact given similarly no significant difference between surgical options could be traced in outcome of 10-year RFS and 20-year OS, p=0.94 and p=0.24, respectively. The pattern of recurrences as a first event in breast conservation vs. mastectomy did not differ significantly irrespective of site, p=0.27. Looking into the type of local relapse, viz., new primaries vs. true recurrences, it appeared that new primaries were significantly associated to BCS, while true recurrences dominated among M treated patients (p<0.001). In conclusion, long-term data indicate that BCS in eligible patients proves as effective as mastectomy both regarding local tumour control, RFS and OS. Local failures as a first event consistent with new primaries are strongly associated with BCS, whereas true recurrence predominates after mastectomy.

Entities:  

Mesh:

Year:  2008        PMID: 18465335     DOI: 10.1080/02841860801971439

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  73 in total

Review 1.  Partial breast irradiation techniques in early breast cancer.

Authors:  Agata Kacprowska; Jacek Jassem
Journal:  Rep Pract Oncol Radiother       Date:  2011-10-14

Review 2.  Hypofractionated radiotherapy for early breast cancer: Review of phase III studies.

Authors:  Agata Kacprowska; Jacek Jassem
Journal:  Rep Pract Oncol Radiother       Date:  2012-02-01

Review 3.  What is a clear margin in breast conserving cancer surgery?

Authors:  Helen Krontiras; Rachael B Lancaster; Marshall M Urist
Journal:  Curr Treat Options Oncol       Date:  2014-03

4.  The adaptation process of a teaching and research hospital to changing trends in modern breast surgery.

Authors:  Mustafa Gökhan Ünsal; Ahmet Cem Dural; Muhammet Ferhat Çelik; Cevher Akarsu; İrfan Başoğlu; M Ece Dilege; Selin Kapan; Halil Alış
Journal:  Ulus Cerrahi Derg       Date:  2014-10-20

5.  Partial-Breast Irradiation - Current Situation with Evidence.

Authors:  Hale Başak Çağlar
Journal:  J Breast Health       Date:  2017-01-01

6.  Predictors of Unemployment After Breast Cancer Surgery: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Li Wang; Brian Y Hong; Sean A Kennedy; Yaping Chang; Chris J Hong; Samantha Craigie; Henry Y Kwon; Beatriz Romerosa; Rachel J Couban; Susan Reid; James S Khan; Michael McGillion; Victoria Blinder; Jason W Busse
Journal:  J Clin Oncol       Date:  2018-05-14       Impact factor: 44.544

7.  Effect of Polygonatum odoratum extract on human breast cancer MDA-MB-231 cell proliferation and apoptosis.

Authors:  Yu Tai; Yi-Ming Sun; Xue Zou; Qiong Pan; Ya-Dong Lan; Qiang Huo; Jing-Wen Zhu; Fei Guo; Chang-Quan Zheng; Cheng-Zhu Wu; Hao Liu
Journal:  Exp Ther Med       Date:  2016-08-30       Impact factor: 2.447

8.  Reconstruction in Breast Conservation Therapy-Single Tertiary Care Institution Experience with 472 Patients.

Authors:  Juhi Agrawal; Sandeep Mehta; Ashish Goel; Veda Padmapriya Selvakumar; Kapil Kumar; Pankaj Kumar Pande
Journal:  Indian J Surg Oncol       Date:  2017-05-05

9.  Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival.

Authors:  Colin S McArdle; Donald C McMillan; Nicola Greenlaw; David S Morrison
Journal:  BMC Cancer       Date:  2010-07-30       Impact factor: 4.430

Review 10.  Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.

Authors:  Rick G Pleijhuis; Maurits Graafland; Jakob de Vries; Joost Bart; Johannes S de Jong; Gooitzen M van Dam
Journal:  Ann Surg Oncol       Date:  2009-07-17       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.